Letzte Suchanfragen
Ergebnisse für *
Zeige Ergebnisse 1 bis 25 von 101.
-
Deaths of despair and the incidence of excess mortality in 2020
-
Three myths about federal regulation
-
The Backward Art of Slowing the Spread? Congregation Efficiencies during COVID-19
-
The Value of Employer-Sponsored Health Insurance
-
The Incidence and Magnitude of the Health Costs of In-person Schooling during the COVID-19 Pandemic
-
Personal Increasing Returns
Analytics and Applications -
Peltzman Revisited
Quantifying 21st Century Opportunity Costs of FDA Regulation -
Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21
-
The Value of Pharmacy Benefit Management
-
Non-Covid Excess Deaths, 2020-21
Collateral Damage of Policy Choices? -
Prices and federal policies in opioid markets
-
Restrict the Middleman?
Quantitative Models of PBM Regulations and Their Consequences -
Beyond Pigou
Externalities and Civil Society in the Supply-Demand Framework -
The Economic Opportunity Cost of Green Recovery Plans
-
A Final Report Card on the States' Response to COVID-19
-
A note on the time-elimination method for solving recursive dynamic economic models
-
Economic activity and the value of medical innovation during a pandemic
-
Ending Pay for PBM Performance
Consequences for Prescription Drug Prices, Utilization, and Government Spending -
Measuring aggregate human capital
-
The empirical frequency of a pivotal vote
-
Labor market search and optimal retirement policy
-
A dual method of empirically evaluating dynamic competitive equilibrium models with market distortions, applied to the Great Depression and World War II
-
A century of labor-leisure distortions
-
Inflation and the size of government
-
Human capital, heterogeneity, and estimated degrees of intergenerational mobility